<code id='44302F6BAD'></code><style id='44302F6BAD'></style>
    • <acronym id='44302F6BAD'></acronym>
      <center id='44302F6BAD'><center id='44302F6BAD'><tfoot id='44302F6BAD'></tfoot></center><abbr id='44302F6BAD'><dir id='44302F6BAD'><tfoot id='44302F6BAD'></tfoot><noframes id='44302F6BAD'>

    • <optgroup id='44302F6BAD'><strike id='44302F6BAD'><sup id='44302F6BAD'></sup></strike><code id='44302F6BAD'></code></optgroup>
        1. <b id='44302F6BAD'><label id='44302F6BAD'><select id='44302F6BAD'><dt id='44302F6BAD'><span id='44302F6BAD'></span></dt></select></label></b><u id='44302F6BAD'></u>
          <i id='44302F6BAD'><strike id='44302F6BAD'><tt id='44302F6BAD'><pre id='44302F6BAD'></pre></tt></strike></i>

          explore

          explore

          author:explore    Page View:241
          Trump Campaign Event In Nevada
          Ethan Miller/Getty Images

          WASHINGTON — Former President Trump is back to campaigning for tying Medicare drug prices to lower prices abroad.

          In Trump fashion, he claimed in a video announcement this month that he is the “only president in modern times” to take on the drug industry — and dinged President Biden directly.

          advertisement

          “Biden canceled my tough-on-pharma policies the moment he had a chance,” Trump said.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          focus

          In age of alternative facts, a scholarly course on calling out crap
          In age of alternative facts, a scholarly course on calling out crap

          Screenshotviacallingbullshit.orgTiredofalternativefacts,fakenews,andbreathlesshyperbole,twoprofessor

          read more
          Pediatric cancer treatments threatened by a new FDA policy
          Pediatric cancer treatments threatened by a new FDA policy

          Themedicalcommunitytodayfacesadeceptivelysimplequestion:Howquicklyshouldweactwhenachild’slifeisonthe

          read more
          Medicare proposal to cover medical devices draws a mixed reaction
          Medicare proposal to cover medical devices draws a mixed reaction

          AdobeThemedicaldeviceindustryissplitonwhetheraproposednewMedicarereimbursementpathwaywilldoanythingt

          read more

          With clinical trial data readouts, here's how to spot spin

          AdobeInvestors,analysts,doctors,andevenpatientsfaceanavalancheofnewsfrombiotechcompaniesabouttheirhu